BST2 and AIDS: While neuroinflammation is a cardinal feature of HAD, antiviral responses including induction of IFN-α, MX-1, PRKRA or BST-2 await clarification of their expression in HAD, although several studies indicate the IFN-α might be increased in the brains of HIV/AIDS patients [67-69].